Clinical Trials Directory

Trials / Completed

CompletedNCT06354413

Outcomes of Concomitant Bypass Surgery in Septal Myectomy

Establishing a Database of Patients Undergoing Surgery for Hypertrophic Cardiomyopathy (Concomitant Bypass Surgery)

Status
Completed
Phase
Study type
Observational
Enrollment
320 (actual)
Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital · Academic / Other
Sex
All
Age
8 Years – 90 Years
Healthy volunteers
Not accepted

Summary

To investigate clinical characteristics and survival outcomes of patients with obstructive hypertrophic cardiomyopathy who underwent concomitant coronary artery bypass grafting during septal myectomy.

Detailed description

Surgical septal myectomy (SM) is an effective approach for treating patients with drug-refractory obstructive hypertrophic cardiomyopathy (HCM).However, numerous patients with HCM exhibit concurrent ischemic heart disease, including atherosclerotic coronary artery disease (CAD) and myocardial bridging (MB). Although patients with HCM have been known to possess diminished coronary flow reserve,additional CAD can worsen myocardial ischemia, contributing to an unfavorable prognosis.MB, although infrequent, may affect diastolic heart perfusion, leading to angina and even sudden death.Current guidelines recommend revascularization for ischemic heart disease caused by CAD and MB.However, the impact of concomitant coronary revascularization during HCM management remains unclear. In this study, we analyzed the clinical characteristics and surgical scenarios of patients who underwent concomitant coronary artery bypass grafting (CABG) during ventricular SM and investigated their prognosis. Patient clinical and survival data from 2009-2020 were retrospectively reviewed. The median follow-up period was 5.1 years. All-cause mortality was the primary endpoint.

Conditions

Interventions

TypeNameDescription
PROCEDURECABG during myectomyTo explore the effect of CABG during myectomy. No control group

Timeline

Start date
2009-01-01
Primary completion
2020-12-01
Completion
2023-12-01
First posted
2024-04-09
Last updated
2024-04-09

Source: ClinicalTrials.gov record NCT06354413. Inclusion in this directory is not an endorsement.